PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.
Saved in:
| Title: | PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody. |
|---|---|
| Authors: | Escuin-Ordinas H; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Elliott MW; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA., Atefi M; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Lee M; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA., Ng C; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Wei L; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA., Comin-Anduix B; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA., Montecino-Rodriguez E; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, USA., Avramis E; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA., Radu C; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA., Sharp LL; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA ; Current address: Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Dr., San Diego, CA 92121, USA., Ribas A; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA ; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA ; Department of Medicine, Division of Hematology-Oncology, 11-934 Factor Building, Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1782, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2013 Aug 27; Vol. 1, pp. 14. Date of Electronic Publication: 2013 Aug 27 (Print Publication: 2013). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: eCollection Cited Medium: Print ISSN: 2051-1426 (Print) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 24829750 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Escuin-Ordinas+H%22">Escuin-Ordinas H</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Elliott+MW%22">Elliott MW</searchLink>; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Atefi+M%22">Atefi M</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Lee+M%22">Lee M</searchLink>; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ng+C%22">Ng C</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Wei+L%22">Wei L</searchLink>; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Comin-Anduix+B%22">Comin-Anduix B</searchLink>; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Montecino-Rodriguez+E%22">Montecino-Rodriguez E</searchLink>; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Avramis+E%22">Avramis E</searchLink>; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Radu+C%22">Radu C</searchLink>; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Sharp+LL%22">Sharp LL</searchLink>; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA ; Current address: Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Dr., San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Ribas+A%22">Ribas A</searchLink>; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA ; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA ; Department of Medicine, Division of Hematology-Oncology, 11-934 Factor Building, Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1782, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2013 Aug 27; Vol. 1, pp. 14. <i>Date of Electronic Publication: </i>2013 Aug 27 (<i>Print Publication: </i>2013). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2051-1426 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24829750 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/2051-1426-1-14 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 14 Titles: – TitleFull: PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Escuin-Ordinas H – PersonEntity: Name: NameFull: Elliott MW – PersonEntity: Name: NameFull: Atefi M – PersonEntity: Name: NameFull: Lee M – PersonEntity: Name: NameFull: Ng C – PersonEntity: Name: NameFull: Wei L – PersonEntity: Name: NameFull: Comin-Anduix B – PersonEntity: Name: NameFull: Montecino-Rodriguez E – PersonEntity: Name: NameFull: Avramis E – PersonEntity: Name: NameFull: Radu C – PersonEntity: Name: NameFull: Sharp LL – PersonEntity: Name: NameFull: Ribas A IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 08 Text: 2013 Aug 27 Type: published Y: 2013 Identifiers: – Type: issn-print Value: 2051-1426 Numbering: – Type: volume Value: 1 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |